top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Kerendia 10mg Tablet

Kerendia 10mg Tablet

Manufacturer/Marketed By : BAYER ZYDUS PHARMA PVT LTD

$13.63 $13.62

Kerendia 10mg Tablet is a medication containing an active component called Finerenone. It falls under the category of nonsteroidal mineralocorticoid receptor antagonists (MRAs). Its purpose is to address conditions associated...

FINERENONE

Active Pharmaceutical Ingredient

Kerendia 10mg Tablet

SKU KERENDIA-10MG-TABLET
Original price

$13.63

Sale price

$13.62

Kerendia 10mg Tablet is a medication containing an active component called Finerenone. It falls under the category of nonsteroidal mineralocorticoid receptor antagonists (MRAs). Its purpose is to address conditions associated with imbalanced levels of mineralocorticoid hormones, specifically aldosterone, within the body. The primary usage of this medication is for the treatment of chronic kidney disease (CKD) in individuals diagnosed with type 2 diabetes. It aids in lowering the likelihood of kidney disease advancement and also mitigates the risk of cardiovascular incidents, such as heart failure, in these patients. Kerendia 10mg Tablet should not be used in individuals with known hypersensitivity or allergy to the drug or its components. It can increase the potassium levels in the blood. It should be used cautiously or avoided in patients with hyperkalemia or those already taking medications that can increase potassium levels (such as potassium-sparing diuretics or potassium supplements). This medication can affect the balance of electrolytes in the body. Monitoring potassium, sodium, and other electrolyte levels may be necessary during treatment. Kerendia 10mg Tablet may affect blood glucose levels, especially in patients with diabetes. If a person is undergoing surgery, it is important to inform the healthcare team about using Kerendia 10mg Tablet, as it may need to be temporarily discontinued before the procedure.

Active Pharmaceutical Ingredient

FINERENONE

Uses

• Chronic kidney disease (CKD) with type 2 diabetes

Benefits

Kerendia 10mg is a selective nonsteroidal mineralocorticoid receptor antagonist (MRA) that blocks the effects of aldosterone, a hormone involved in fluid balance and blood pressure regulation. Inhibiting mineralocorticoid receptors reduces sodium and water retention, prevents potassium excretion, and provides therapeutic benefits in chronic kidney disease, including slowing disease progression, reducing cardiovascular risk, and controlling blood pressure.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Most Common Side Effects

• Hyperkalemia (high levels of potassium in the blood)
• Diarrhea
• Dizziness
• Fatigue
• Headache
• Nausea
• Hypotension (low blood pressure)

Common Side Effects

• Severe allergic reactions (e.g., rash, itching, swelling, severe dizziness, difficulty breathing)
• Worsening of kidney function or acute kidney injury
• Liver problems (e.g., jaundice, dark urine, abdominal pain)
• Severe hyperkalemia (symptoms can include muscle weakness, irregular heartbeat, and palpitations)
• Hypotension leading to fainting or loss of consciousness

How To Use

To use Kerendia 10mg Tablet, follow the prescribed dosage and instructions provided by your healthcare provider. Take the medications as directed, usually orally, with or without food. Do not skip doses or stop taking them without consulting your healthcare provider. Consult your healthcare provider or pharmacist for guidance if you have any questions or concerns.

Safety Advice

• Breast Feeding: Breastfeeding is not recommended along with the treatment of Kerendia 10mg Tablet.
• Alcohol: It is unsafe to drink alcohol while taking Kerendia 10mg Tablet. It may reduce the drug's effectiveness and can cause toxic side effects.
• Liver: It is important to discuss your specific lung condition with your healthcare provider, as they can provide personalized advice based on your medical history and individual needs.
• Lungs: Kerendia 10mg Tablet is contraindicated for severe liver impairment. Prior liver conditions or concerns should be communicated to the healthcare provider before starting it. For mild to moderate liver impairment, caution with potential dose adjustments and regular liver function monitoring is advised.
• Driving: Kerendia 10mg Tablet can cause dizziness. It is recommended to avoid driving and operating heavy machinery during the treatment.
• Pregnancy: Kerendia 10mg Tablet may cause harm to an unborn baby. Inform your doctor if you are pregnant or planning to get pregnant before taking it. The doctor will explain the potential risks and benefits.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page